Evidence map›Paper›PMID 41492568›Full record

ArticleAmerican journal of ophthalmology case reports2026

Ophthalmic phenotype associated with a novel mutation in

Khawlah A Alzaben, Amani Albakri, Rawan S Alshabeeb, Naif Almontashiri, Khaled K Abu-Amero, Nouf A Alzendi

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khawlah A AlzabenOculoplastic and Orbit Division, King Khaled Eye Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Amani AlbakriPediatric and strabismus Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Rawan S AlshabeebAnterior Segment Division, King Khaled Eye Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Naif AlmontashiriResearch Dept. King Khaled Eye Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Khaled K Abu-AmeroResearch Dept. King Khaled Eye Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Nouf A AlzendiGlaucoma Division, King Khaled Eye Specialist Hospital & Research Center, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intermediate Junctional Epidermolysis Bullosa (JEB) is an extremely rare condition, with an incidence of slightly more than two per million live births. Patients with Epidermolysis Bullosa are classified using the "onion skinning" approach, which includes the major EB type, phenotypic characteristics, inheritance mode, targeted protein and its skin expression, gene involved, mutation types, and specific mutation(s) and location. This facilitates recognition of syndromic EB and aids in genetic counseling. Purpose: To report a patient with Intermediate JEB, perform a detailed ophthalmic evaluation, and identify the genetic cause through testing. Results: A 13-year-old girl presented with recurrent epithelial erosions since 2015, with minimal or no trauma. Ophthalmic exam revealed bilateral faint corneal opacities and prominent corneal innervation. Systemic findings included hypodontia and hypopigmentation of the forearms and retroauricular region. Whole exome sequencing revealed a homozygous c.2137+2T > G variant in the Conclusion: The ocular, dental, and dermal findings support a diagnosis of EB, highlighting the importance of multidisciplinary evaluation. Identification of this novel

Indexed as

BlisteringDental cariesHypodontiaLAMB3Recurrent epithelial erosionsSyndromic intermediate junctional epidermolysis bullosa

Identifiers

PMID41492568
PMCPMC12765158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.